JPRN-UMIN000022281
Recruiting
未知
Research on gene expression regulated by long-term erythromycin therapy for chronic respiratory disease - Research on gene expression regulated by long-term erythromycin therapy for chronic respiratory disease
Department of Pathophysiology and Host Defense, The Research Institute of Tuberculosis -Japan Anti-Tuberculosis Association0 sites20 target enrollmentMay 11, 2016
Conditionschronic respiratory disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- chronic respiratory disease
- Sponsor
- Department of Pathophysiology and Host Defense, The Research Institute of Tuberculosis -Japan Anti-Tuberculosis Association
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients who change their medicine except for erythromycin 1 month before treatment and 4\~8 weeks after treatment 2\)Patients who need to receive standard of care
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
The complete placental transcriptome in health and disease in pregnant Caucasian womeGene expression in placentas collected from fetuses from pregnancies complicated by preeclampsia or intrauterine growth restriction compared to those from healthy pregnancies.Reproductive Health and Childbirth - Fetal medicine and complications of pregnancyACTRN12612001179820The University of Adelaide600
Not yet recruiting
Phase 2
Treatment of Rheumatoid Arthritis with Unani Medicine and its relation with genesHealth Condition 1: D898- Other specified disorders involving the immune mechanism, not elsewhere classifiedCTRI/2023/05/053034Central Council for Research in Unani Medicine
Active, not recruiting
Phase 1
Gene and protein expression after treatment of actinic keratosisActinic keratosesMedDRA version: 20.0Level: PTClassification code 10000614Term: Actinic keratosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2021-005996-37-DKZealand University Hospital60
Recruiting
Phase 2
The Effect of Tacrolimus in patients with recurrent implantation failureRecurrent Implantation Failure.Female infertility of uterinN-97.2IRCT20171007036623N1Shahid Beheshti University of Medical Sciences10
Recruiting
Not Applicable
The NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC) Follow-up Studycongenital heart diseaseCardiovascular - Other cardiovascular diseasesSurgery - Other surgeryACTRN12621000904875The University of Queensland868